We are live on ! Find out more
EAM

Exos Asset Management Portfolio holdings

AUM $2.32K
1-Year Est. Return 108.13%
This Fund
S&P 500
This Quarter Est. Return
+6.79%
1 Year Est. Return
+108.13%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$61.1M
AUM Growth
Cap. Flow
+$58.9M
Cap. Flow %
96.41%
Top 10 Hldgs %
15.81%
Holding
245
New
245
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Financials 21.08%
2 Healthcare 7.65%
3 Consumer Discretionary 7.24%
4 Industrials 6.1%
5 Technology 4.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KSMTU
151
DELISTED
Kismet Acquisition One Corp Unit
KSMTU
$71K 0.12%
+6,800
New +$68.7K
LOTZ
152
DELISTED
CarLotz, Inc. Class A Common Stock
LOTZ
$68K 0.11%
+6,042
New +$62.1K
CELU icon
153
Celularity
CELU
$19.3M
$66K 0.11%
+600
New +$63.8K
HIGA.WS
154
DELISTED
H.I.G. Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HIGA.WS
$66K 0.11%
+50,000
New +$68.6K
MACUU
155
DELISTED
Mallard Acquisition Corp. Unit
MACUU
$66K 0.11%
+6,202
New +$62.8K
ERESU
156
DELISTED
East Resources Acquisition Company Unit
ERESU
$64K 0.1%
+6,035
New +$61.1K
BURU.WS
157
DELISTED
Nuburu, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
BURU.WS
$63K 0.1%
+45,000
New +$47K
CTAQU
158
DELISTED
Carney Technology Acquisition Corp. II Units
CTAQU
$62K 0.1%
+6,000
New +$61.6K
HZAC
159
DELISTED
Horizon Acquisition Corporation
HZAC
$60K 0.1%
+6,001
New +$60.2K
MLTX icon
160
MoonLake Immunotherapeutics
MLTX
$1.49B
$57K 0.09%
+5,000
New +$53.1K
PWP icon
161
Perella Weinberg Partners
PWP
$1.25B
$56K 0.09%
+5,000
New +$52.1K
BLSA
162
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
$56K 0.09%
+5,000
New +$53.6K
SPRQ.U
163
DELISTED
Spartan Acquisition Corp. II Units, each consisting of one share of Class A common stock, and one-ha
SPRQ.U
$54K 0.09%
+5,000
New +$52.9K
DEH.WS
164
DELISTED
D8 Holdings Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exer
DEH.WS
$52K 0.09%
+50,000
New +$38.1K
CAPAU
165
DELISTED
HighCape Capital Acquisition Corp. Unit
CAPAU
$52K 0.09%
+5,000
New +$50.8K
SAII
166
DELISTED
Software Acquisition Group Inc. II Class A Common Stock
SAII
$46K 0.08%
+4,628
New +$45.4K
LVOX
167
DELISTED
LiveVox Holding, Inc. Class A Common Stock
LVOX
$43K 0.07%
+4,109
New +$41.8K
CRHC
168
DELISTED
Cohn Robbins Holdings Corp.
CRHC
$43K 0.07%
+4,160
New +$41.5K
JIH
169
DELISTED
Juniper Industrial Holdings, Inc.
JIH
$43K 0.07%
+4,000
New +$41.2K
TMPOW
170
DELISTED
Tempo Automation Holdings, Inc. Warrant
TMPOW
$42K 0.07%
+30,000
New +$26K
DEH.U
171
DELISTED
D8 Holdings Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemabl
DEH.U
$40K 0.07%
+3,729
New +$38K
PDAC.WS
172
DELISTED
Peridot Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordina
PDAC.WS
$40K 0.07%
+22,500
New +$32.5K
QSIAW
173
DELISTED
Quantum-Si Inc Warrant
QSIAW
$37K 0.06%
+32,207
New +$36.4K
LFTR
174
DELISTED
Lefteris Acquisition Corp. Class A Common Stock
LFTR
$36K 0.06%
+3,431
New +$35.5K
MSPRZ
175
DELISTED
MSP Recovery Inc Warrant
MSPRZ
$35K 0.06%
+30,000
New +$27.4K

Similar funds

Exos Asset Management's Q4 2020 Portfolio in Review

Q4 2020 is the first quarter with a 13F filing on record for Exos Asset Management, which disclosed 245 positions worth $61.1M. Its ten largest holdings account for 16% of the portfolio.

Its largest position is NUBURU INC: 593 shares worth $1.23M.

By sector, the portfolio is most concentrated in Financials at 21% of assets, followed by Healthcare and Consumer Discretionary.

  • Exos Asset Management's largest Q4 2020 buy was NUBURU INC: 593 shares worth $1.23M.
  • Exos Asset Management's ten largest holdings make up 16% of its $61.1M portfolio in Q4 2020.
  • Exos Asset Management disclosed 245 positions in Q4 2020, its first 13F filing on record.

Based on Exos Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.